The mechanism of the effect of HSP70 on prostate cancer cells is based on the direct interaction of the substrate-binding domain of this protein with the NTD domain of AR, as confirmed by the study by Dong et al. [130]. This evidence concerns the gene AR and prostate carcinoma.